Sunday, March 29, 2015

Deals

Google Partners with Johnson & Johnson

March 29, 2015 · Leave a Comment 

  Google and Johnson & Johnson have announced that they will be collaborating together in the development of an advanced, robot-assisted surgery platform. The joint effort will involve “capabilities, intellectual property and expertise” from both companies, along with Johnson & Johnson subsidiary Ethicon, maker of medical devices. More specifically, Google and Ethicon will be collaborating on the development of surgical robots intended for assistance in operating rooms. Robotic-assisted surgery is a type of minimally invasive surgery that uses technology to give surgeons... [Read the full story]

Deal News

Google Partners with Johnson & Johnson

March 29, 2015 · Leave a Comment 

  Google and Johnson & Johnson have announced that they will be collaborating together in the development of an advanced, robot-assisted surgery platform. The joint effort will involve “capabilities, intellectual property and expertise” from both companies, along with Johnson & Johnson subsidiary Ethicon, maker of medical devices. More specifically, Google and Ethicon will be collaborating on the development of surgical robots intended for assistance in operating rooms. Robotic-assisted surgery is a type of minimally invasive surgery that uses technology to give surgeons... [Read the full story]

Legal

Semafone and Eckoh agree to settlement

March 19, 2015 · Leave a Comment 

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed to a confidential settlement of their dispute over alleged infringement and invalidity of Semafone’s UK Patent (No. GB 2,473,376), to the mutual benefit of both parties.  Under the settlement, Semafone has granted a worldwide licence to their granted patents, trademarks and patent applications covering certain dual tone multi-frequency (“DTMF”) masking methods of taking secure payments over the phone, for the benefit of Eckoh, its customers and suppliers. In consideration of the licence, Eckoh... [Read the full story]

Bio

Google Partners with Johnson & Johnson

March 29, 2015 · Leave a Comment 

  Google and Johnson & Johnson have announced that they will be collaborating together in the development of an advanced, robot-assisted surgery platform. The joint effort will involve “capabilities, intellectual property and expertise” from both companies, along with Johnson & Johnson subsidiary Ethicon, maker of medical devices. More specifically, Google and Ethicon will be collaborating on the development of surgical robots intended for assistance in operating rooms. Robotic-assisted surgery is a type of minimally invasive surgery that uses technology to give surgeons... [Read the full story]

University Tech Transfer

Avalanche Biotechnologies (AAVL) Enters Exclusive License Agreement with University of Washington

March 25, 2015 · Leave a Comment 

  Avalanche Biotechnologies (Nasdaq: AAVL) today announced that it has entered into an exclusive license agreement with the University of Washington (UW) in Seattle to develop products based on Avalanche’s proprietary Ocular BioFactory™ Platform for the treatment of color vision deficiency (CVD), commonly known as red-green color blindness. Avalanche also announced today, outside of the scope of the license agreement, that Drs. Jay and Maureen Neitz, faculty in the UW’s Department of Ophthalmology and CVD experts, have joined its Scientific Advisory Board. They will be technical... [Read the full story]

People

IP Industry: we start here

March 8, 2015 · Leave a Comment 

In 2007, we set out to change the world of intellectual property, and how innovation and ideas were exchanged among IP owners and those that desired IP. We knew there were significant headwinds with an entrenched, decades-old ecosystem of long held beliefs about the “way things ought to be done” and who were we to come along and try to change things. None of this did anything to deter us; it drove us even harder. Not to gloat or brag, but many of the world’s LARGEST IP Owners and Transactors are now our customers- more on that in later posts.  They see the same future. IP Attorneys said... [Read the full story]

Deals

Google Partners with Johnson & Johnson

  Google and Johnson & Johnson have announced that they will be collaborating together in the development of an advanced, robot-assisted surgery platform. The joint effort will involve “capabilities, intellectual property and expertise” from both companies, along with Johnson & Johnson subsidiary Ethicon, maker of medical devices.... Read more of this article


World Patent Marketing China Unveils Production of the Hot Tub Swivel Seat

  SHANGHAI, China, March 27, 2015 (GLOBE NEWSWIRE) — via PRWEB – World Patent Marketing, the world’s fastest growing vertically integrated manufacturer of patented products, is pleased to announce that it has successfully negotiated a licensing deal for an Indiana inventor. The manufacturer is none other then World Patent Marketing... Read more of this article


Rovi Enters into License Agreement with CJ HelloVision

  SANTA CLARA, Calif., March 27, 2015 – Rovi Corporation (NASDAQ: ROVI) today announced that Rovi has entered into a new interactive program guide (IPG) patent portfolio license agreement with CJ HelloVision, one of Korea’s largest multi-system operators (MSO) and a leading TV everywhere and video-on-demand (VOD) service provider. The... Read more of this article


RXI Pharma Enters Exclusive License Deal with MirImmune

    RXI Pharma (NASDAQ: RXII) and privately-held MirImmune LLC, today announced that they have entered into an exclusive license agreement to RXi’s novel and proprietary sd-rxRNA® technology for use in developing innovative cell-based cancer immunotherapies. The collaboration has the potential to result in novel, more effective and... Read more of this article


Stemedica: Worldwide License

Stemedica Cell Technologies Inc., (Stemedica), announced that Universal Stabilization Technologies (UST) has granted to Stemedica subsidiary StemProtein, LLC, an exclusive worldwide license to its technology known as Preservation by Vaporization (PBV) for industrial scale stabilization of stem cells and stem cell derivatives. This... Read more of this article


Acacia Subsidiary Enters into Patent License Agreement with Leica Microsystems

  NEWPORT BEACH, Calif., Mar 26, 2015 (BUSINESS WIRE) — Acacia Research Corporation ACTG, -1.46% announced today that its Super Resolution Technologies LLC subsidiary has entered into a settlement and patent license agreement with Leica Microsystems GmbH and Leica Microsystems Inc. The agreement resolves litigation that was pending in the... Read more of this article


Betafence Announces Acquisition Of IP Rights From Gibraltar US

  ENNIS, Texas, March 25, 2015 /PRNewswire/ — Betafence, the worldwide leader in the market of comprehensive solutions for high security perimeter protection, has announced that it has acquired the intellectual property rights to cable-based anti-ram crash fences, barriers and gates from Gibraltar US, a leader in crash barrier products and... Read more of this article


Applied DNA Sciences and Divatex Sign Agreement

  Applied DNA Sciences, Inc. (NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, supply chain and product authentication solutions, has entered into a mutual license agreement with Divatex, a leading supplier of home textiles, to commercialize the world’s first supply-chain-DNA-verified cotton product.... Read more of this article


Avalanche Biotechnologies (AAVL) Enters Exclusive License Agreement with University of Washington

  Avalanche Biotechnologies (Nasdaq: AAVL) today announced that it has entered into an exclusive license agreement with the University of Washington (UW) in Seattle to develop products based on Avalanche’s proprietary Ocular BioFactory™ Platform for the treatment of color vision deficiency (CVD), commonly known as red-green color blindness. Avalanche... Read more of this article


Biohaven enters into license deal for Catalent’s Zydis ODT technology

  Biohaven Pharmaceutical (Biohaven) has entered into an exclusive world-wide agreement with Catalent Pharma Solutions for its Zydis Orally Disintegrating Tablet (ODT) technology to be used in the development of Biohaven’s lead drug development candidate, BHV-0223. Canada-based Portage Biotech holds 54% equity of Biohaven, a privately-held... Read more of this article


More Posts From Deals

Legal

Semafone and Eckoh agree to settlement

  Guildford, Surrey, 19th March 2015 – Eckoh plc and Semafone® have agreed... 


Iteris, Wavetronix Settle Patent Infringement Litigation

  SANTA ANA, Calif.–Iteris, Inc. (NYSE MKT: ITI), a leader in providing... 


More Posts From Legal

University Tech Transfer

Avalanche Biotechnologies (AAVL) Enters Exclusive License Agreement with University of Washington

  Avalanche Biotechnologies (Nasdaq: AAVL) today announced that it has entered... 


Scottish partnership to develop photonics techniques

  Scotland-based M Squared Lasers is partnering with the University of St Andrews... 


More Posts From University Tech Transfer